← Eichor
Condition: Multi Drug Resistant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Multi Drug Resistant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Myeloma Novel Drug Discovery Ver 1.2
Phase N/A · 1 location(s) · Institute of Cancer Research, United Kingdom · NCT05968417Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) Durin
Phase 4 · 1 location(s) · Marco Schiuma · NCT07477119Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuber
Phase 3 · 2 location(s) · Katarzyna Kotulska · NCT05534672Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
Phase 1/Phase 2 · 26 location(s) · Sanofi · NCT04643002FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
Phase 1/Phase 2 · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05791396CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
EARLY_Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07586267Household Transmission Dynamics of Multidrug Resistant Enterobacterales
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05798364Evaluation of the NaviFUS System in Drug Resistant Epilepsy
NA · 1 location(s) · Genovate-NaviFUS (Australia) Pty Ltd. · NCT05947656A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Dr
Phase 1/Phase 2 · 3 location(s) · NaviFUS Corporation · NCT06388707To Compare the Effects of Herbal Medicines With Traditional Allopathic Medicines in Cases of Patients With Metabolic Syn
NA · 1 location(s) · Hamdard University · NCT06515652Infection Risk Associated With Digestive MDRO Carriage in Hospitalized Patients
Phase N/A · 1 location(s) · Valeriu Gheorghita · NCT07134270A PAN-USR TB Multi-Center Trial
Phase 3 · 3 location(s) · Shenzhen Third People's Hospital · NCT06905522Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant
Phase 3 · 10 location(s) · Newron Pharmaceuticals SPA · NCT07184619Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Phase 1/Phase 2 · 11 location(s) · Georgiamune Inc · NCT06425926Structural-functional Connectome in Drug-resistant Epilepsies and Neurodevelopmental Syndromes With Epilepsy
Phase N/A · 1 location(s) · IRCCS Eugenio Medea · NCT06353620Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and
Phase N/A · 1 location(s) · Castagna Antonella · NCT04098315National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor
Phase 1 · 3 location(s) · Novartis Pharmaceuticals · NCT07570979Effects of Antipsychotics on Brain Insulin Action in Females
NA · 1 location(s) · Centre for Addiction and Mental Health · NCT06251635Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases
Phase N/A · 1 location(s) · Chang Gung Memorial Hospital · NCT07248371A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers
Phase 1 · 1 location(s) · Bugworks Research Inc. · NCT07029932Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS
Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT06553898SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
Phase N/A · 1 location(s) · University of California, San Francisco · NCT00187512Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06782880Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa
Phase N/A · 48 location(s) · Centre Hospitalier Régional d'Orléans · NCT06738771Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
EARLY_Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT06792799An Adaptive Randomized Controlled Trial
NA · 1 location(s) · Columbia University · NCT05633056Development of a Swiss Surveillance Database for Molecular Epidemiology of Hypervirulent and Multi-drug Resistant Pathog
Phase N/A · 5 location(s) · University Hospital, Basel, Switzerland · NCT04172025LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering
Phase 4 · 1 location(s) · University of California, San Diego · NCT06865885100-Year Human Aging Study
Phase N/A · 1 location(s) · Longevity Metrics, Inc. · NCT07563777
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.